The influence of a single dose of vasopressin analogs on human renal potassium excretion.
@article{Ndvornkov1982TheIO, title={The influence of a single dose of vasopressin analogs on human renal potassium excretion.}, author={H. N{\'a}dvorn{\'i}kov{\'a} and Otto Sch{\"u}ck}, journal={International journal of clinical pharmacology, therapy, and toxicology}, year={1982}, volume={20 4}, pages={ 155-8 } }
The effect of intranasal administration of 10 micrograms of 1-deamino-8-d-arginine vasopressin (DDAVP) and intravenous administration of 200 micrograms of N-glycyl-glycyl-glycyl-lysin-vasopressin (TGLVP) on urinary concentration (UK) and fractional excretion (FEK) of potassium was investigated in healthy subjects. For comparison the same parameters were followed under conditions of 36-h water-intake restriction. Once the maximally concentrated urine had been reached, the average value of UK…
10 Citations
Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists.
- Biology, MedicineJournal of the American Society of Nephrology : JASN
- 2008
The mechanisms by which arginine vasopressin (AVP) exerts its antidiuretic and pressor effects, via activation of V2 and V1a receptors, respectively, are relatively well understood, but the possible…
Short-term effects of desmopressin on water and electrolyte excretion in adults with nocturnal polyuria.
- Medicine, BiologyThe Journal of urology
- 2007
Terlipressin causing a hyponatraemic seizure
- MedicineScandinavian journal of gastroenterology
- 2007
The patient the authors report here is unique, with the rapid onset of hyponatraemia and associated seizure due to Terlipressin, and the case demonstrates the need for frequent electrolyte monitoring whilst administering the drug.
Safety of Terlipressin for Hepatorenal Syndrome
- Medicine
- 2011
Terlipressin is contraindicated or should be used with extreme caution in patients with severe atherosclerotic cardiovascular disease and prevention and handling of side effects include careful selection of patients, close surveillance, daily consideration of dose and duration of therapy.
Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome
- MedicineAdvances in therapy
- 2008
Treatment with terlipressin and albumin is considered the most efficient therapy and should therefore be recommended for the treatment of type 1 HRS-1.
Rein, vasopressine et pression artérielle : importance de la concentration de l'urine et du rythme nycthéméral d'excrétion d'eau et de sodium
- Philosophy
- 2008
La vasopressine (AVP), ou hormone antidiuretique, a deux effets majeurs : 1°) des effets sur la permeabilite a l'eau du canal collecteur renal, medies par les recepteurs V2, qui permettent la…
Baseline Renal Function Predicts Hyponatremia in Liver Cirrhosis Patients Treated with Terlipressin for Variceal Bleeding
- MedicineGastroenterology research and practice
- 2017
The presence of HBV, DM, the baseline serum sodium, shock on admission, and especially baseline creatinine may be predictive of the development of hyponatremia after terlipressin treatment.
Terlipressin avoids hemodialysis in the treatment of refractory hyperkalemia associated with renal dysfunction in cirrhosis.
- MedicineThe American journal of medicine
- 2005
The effect of triglycyl-lysine-vasopressin (terlipressin INN, Glypressin) on skin blood flow, measured with laser Doppler flowmetry, thermography and plethysmography. A dose-response study.
- MedicineScandinavian journal of plastic and reconstructive surgery and hand surgery
- 1987
The study supports earlier findings and suggests a dose level of TGLVP for the use in excision of burns, which is less sensitive for detecting effects of T GLVP than laser Doppler flowmetry.